International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 117 | Views: 194

Research Paper | Gynaecology | India | Volume 5 Issue 10, October 2016

Effect of Lucronil? Tablets in the Patients with Leucorrhea: An Open Clinical Trial

Supriya Bhalerao | Swati Mohite | Sneha Kulkarni | Dr. Veena Deo | BK. Shrikhande

Abstract: Leucorrhoea is a common gynaecological problem causing discomfort and disturbance in day to day activities of women. In view of unavailability of specific treatment to manage the condition, we evaluated efficacy and safety of Tab. Lucronil on the clinical signs and symptoms of Leucorrhea. After obtaining Ethics Committee permission and written informed consent, a total of 31 patients were recruited in the study. These patients were asked about the color, odor, consistency and degree of vaginal discharge before and after the treatment. Cervical smear was also collected to assess inflammatory changes. Tab. Lucronil was administered as two tablets (500 mg) twice a day after meals with water for a period of one month. We observed that Tab. Lucronil reduced the symptoms of Leucorrhoea in 8 patients within the duration of 15 days. The remaining 23 patients showed significant reduction (p < 0.001) in the degree of cervical discharge and inflammation (p<0.01). There were no adverse effects reported during the study period. Tab. Lucronil was well tolerated by all the patients as evident from the good compliance. Our study thus highlights the efficacy and safety of Tab. Lucronil in leucorrhoea.

Keywords: Lucronil Leucorrhea

Edition: Volume 5 Issue 10, October 2016,

Pages: 1338 - 1342

How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link

Verification Code will appear in 2 Seconds ... Wait